Hip
Senior Member
- Messages
- 18,118
Hi Nanonug
With your hypothesis that ME/CFS may involve mast cell activation, I just wondered if you have experimentally tested any of the standard drugs that are used to treat mast cell disorders, and if so, what benefits you found these drugs offered your ME/CFS?
Some of the drugs used to treat mast cell disorders and mastocytosis are the following:
With your hypothesis that ME/CFS may involve mast cell activation, I just wondered if you have experimentally tested any of the standard drugs that are used to treat mast cell disorders, and if so, what benefits you found these drugs offered your ME/CFS?
Some of the drugs used to treat mast cell disorders and mastocytosis are the following:
Management
This is concerned mainly with symptom control, as there is currently no cure. Systemic mastocytosis is usually managed by haematologists.
Acute anaphylaxis
Skin and vascular symptoms
- Those prone to acute severe symptoms should avoid trigger factors where possible, wear a MedicAlert® bracelet and carry written treatment protocols from their specialist.
- Acute anaphylaxis is treated with intramuscular adrenaline (epinephrine), antihistamines (H1 and H2 receptor blockers), fluids and pressor agents.
- Patients with recurrent anaphylactoid reactions should carry injectable adrenaline (epinephrine) in pen format for emergency use.
- Consider immunotherapy against insect venom.
Bronchospasm
- For pruritus, weals and flushing - H1 and H2 receptor antagonists such as chlorphenamine, ketotifen and cimetidine.
- Mast cell stabilizers: sodium cromoglicate, nedocromil and ketotifen.
- Local corticosteroids for skin lesions. Intralesional steroid injection is sometimes used.
- Psoralen in combination with ultraviolet A (PUVA) treatment - gives temporary benefit for skin lesions.
Gastrointestinal symptoms
- Inhaled bronchodilators, eg salbutamol.
Other possible systemic treatments
- H2 receptor antagonists or proton pump inhibitors for peptic ulceration.
- Oral sodium cromoglicate for diarrhoea and abdominal pain.
- Anticholinergics for diarrhoea.
Bone pain
- Leukotriene inhibitors have been used in the treatment of systemic mastocytosis.
- Systemic corticosteroids may be helpful for malabsorption, ascites, and bone pain, to prevent anaphylaxis and for severe skin disease.
- Low-dose aspirin may be helpful for symptoms resistant to H1 and H2 antagonists alone, but must be started cautiously under supervision:
- The patient, premedicated with H1 and H2 antihistamines, may take small doses of aspirin, titrated slowly to reach a plasma level of 20-30 mg/100 mL.
- Treatment should be started in a controlled environment, because aspirin can induce mast cell mediator release and subsequent cardiovascular collapse.
Drugs to avoid
- Oral sodium cromoglicate may help.
- Osteoporosis prevention/treatment - calcium, vitamin D, and bisphosphonates.
Aggressive disease
- Beta-blockers are contra-indicated in patients with systemic mastocytosis undergoing surgery - these drugs may counteract endogenous adrenaline (epinephrine) and may precipitate anaphylaxis.
- Avoid alpha-blockers and cholinergic antagonists.
Source: www.patient.co.uk/doctor/Mastocytosis-and-Mast-Cell-Disorders.htm
- Splenectomy may be helpful for patients with significant hypersplenism or portal hypertension (it may reduce the mast cell burden and improve cytopenias).
- Aggressive systemic forms of mastocytosis may be treated with interferon alfa, with or without corticosteroids, or cladribine. In some cases, more intensive treatments such asimatinib, or drug combinations, may be considered.
- Bone marrow transplantation may be considered in some extreme cases but is currently experimental treatment.
- For patients with mast cell sarcoma, surgical excision with consecutive radiation and/or high-dose chemotherapy.